0001576280-22-000029.txt : 20220511 0001576280-22-000029.hdr.sgml : 20220511 20220511205415 ACCESSION NUMBER: 0001576280-22-000029 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220501 FILED AS OF DATE: 20220511 DATE AS OF CHANGE: 20220511 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kalia Kumud CENTRAL INDEX KEY: 0001927831 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38683 FILM NUMBER: 22915356 MAIL ADDRESS: STREET 1: 505 PENOBSCOT DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Guardant Health, Inc. CENTRAL INDEX KEY: 0001576280 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 454139254 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3000 HANOVER STREET CITY: PALO ALTO STATE: CA ZIP: 94304 BUSINESS PHONE: 855-698-8887 MAIL ADDRESS: STREET 1: 3000 HANOVER STREET CITY: PALO ALTO STATE: CA ZIP: 94304 3 1 wf-form3_165231683923225.xml FORM 3 X0206 3 2022-05-01 0 0001576280 Guardant Health, Inc. GH 0001927831 Kalia Kumud 505 PENOBSCOT DR REDWOOD CITY CA 94063 0 1 0 0 Chief Information Officer COMMON STOCK 20530 D RESTRICTED STOCK UNITS 0.0 COMMON STOCK 41747.0 D STOCK OPTION (RIGHT TO BUY) 117.61 2031-11-01 COMMON STOCK 22726.0 D STOCK OPTION (RIGHT TO BUY) 74.0 2030-04-20 COMMON STOCK 28670.0 D (1)The Restricted Stock Units consist of three grants totaling 41,747 shares outstanding as of May 1, 2022. The first grant was granted on April 20, 2020, of which 10,751 shares are outstanding and vests 25% annually commencing on January 7, 2020. The second grant was granted on September 11, 2020, of which 19,633 shares are outstanding and vests 25% annually commencing on September 9, 2020. The third grant was granted on November 2, 2021, of which 11,363 shares are outstanding, and vests 25% on the first anniversary and quarterly thereafter commencing on September 1, 2021. Not applicable to Restricted Stock Units. The stock option vests and becomes exercisable as to 25% of the shares on September 1, 2022, and then in equal monthly installments through September 1, 2025. The stock option vests and becomes exercisable as to 25% of the shares on January 7, 2021, and then in equal monthly installments through January 7, 2024. John Saia 2022-05-11